$2.10
arrow_drop_down5.60%Key Stats | |
---|---|
Open | $2.21 |
Prev. Close | $2.23 |
EPS | -0.85 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $422.49M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.06 | 2.24 |
52 Week Range | 0.70 | 3.40 |
Ratios | |
---|---|
EPS | -0.85 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update
Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe)
19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. George L. Bakris
Esperion Reports Second Quarter 2024 Financial Results and Provides a Business Update
Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility
Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?